Resgen Board Approves Audited FY26 Standalone & Consolidated Results

Resgen Limited's Board of Directors convened on May 28, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results for the half year and full financial year ended March 31, 2026. The Board, acting on the Audit Committee's recommendation, took these results on record, along with the Statement of Assets and Liabilities and the Audit Report. The statutory auditors issued an unmodified opinion on the financial statements. Additionally, the company announced that the trading window would remain closed for 48 hours following the public disclosure of these results, in compliance with SEBI (Prevention of Insider Trading) Regulations, 2015.